PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1106
https://www.valueinhealthjournal.com/article/S1098-3015(12)02819-7/fulltext
Section Title :
Infection
Section Order :
611
First Page :
A392
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02819-7&doi=10.1016/j.jval.2012.08.1106